{"title":"Why Do Safer Nail Product Alternatives Remain Out of Reach?","authors":"Emma Scott, Craig G Burkhart","doi":"10.1111/ijd.70305","DOIUrl":"https://doi.org/10.1111/ijd.70305","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146051894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Samantha Bestavros, Ryan S Q Geng, Jeffrey Donovan
{"title":"Frontal Fibrosing Alopecia and Its Association With Genital Lichen Planus and Lichen Sclerosus: A Systematic Review.","authors":"Samantha Bestavros, Ryan S Q Geng, Jeffrey Donovan","doi":"10.1111/ijd.70287","DOIUrl":"https://doi.org/10.1111/ijd.70287","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146043967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sahithi Talasila, Umer Nadir, George M Jeha, Stanislav N Tolkachjov
{"title":"Diagnostic Implications of Dupilumab-Refractory Atopic Dermatitis: Risk of Underlying Cutaneous T-Cell Lymphoma and the Role of Skin Biopsy.","authors":"Sahithi Talasila, Umer Nadir, George M Jeha, Stanislav N Tolkachjov","doi":"10.1111/ijd.70307","DOIUrl":"https://doi.org/10.1111/ijd.70307","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146029690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diana Schellin, Sarah Rösing, Nick Zimmermann, Nicolai Leuchten, Martin Aringer, Claudia Günther
Background: The aim was to assess the long-term effect of belimumab on the cutaneous manifestations of patients with systemic lupus erythematosus (SLE).
Methods: The retrospective analysis included 29 patients with SLE. Cutaneous disease activity was assessed using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and the Revised CLASI (RCLASI) activity scores before treatment with belimumab and at 3, 6, 12, and up to 60 months of treatment. Eleven patients were treated for the whole observation period; however, only 8 patients were evaluable at 48 months, and only 6 at 60 months due to loss of follow-up.
Results: Compared to the baseline score, a significant reduction of the CLASI and RCLASI activity score was seen during the treatment (mean CLASI baseline 8.76 ± 5.12, after 3 months 5.59 ± 3.87, p < 0.001, after 60 months 4.67 ± 3.86, p = 0.017; mean RCLASI baseline 10.93 ± 6.57, after 3 months 7.62 ± 6.03, after 60 months 5.33 ± 4.31, p = 0.012). The percentage of patients achieving a CLASI 100 response increased continuously over time, reaching a maximum of 30% after 60 months. Response was most remarkable among patients with acute or discoid cutaneous lupus. The treatment was well tolerated by the patients, with the most common adverse events being respiratory infections, headaches, and arthralgia, among others.
Conclusion: This retrospective analysis demonstrated that belimumab has long-term benefits for cutaneous manifestations of patients with lupus erythematosus. However, prospective studies in larger patient populations are needed to confirm the findings.
{"title":"Effect of Belimumab on the Cutaneous Manifestations of Patients With Lupus Erythematosus.","authors":"Diana Schellin, Sarah Rösing, Nick Zimmermann, Nicolai Leuchten, Martin Aringer, Claudia Günther","doi":"10.1111/ijd.70251","DOIUrl":"https://doi.org/10.1111/ijd.70251","url":null,"abstract":"<p><strong>Background: </strong>The aim was to assess the long-term effect of belimumab on the cutaneous manifestations of patients with systemic lupus erythematosus (SLE).</p><p><strong>Methods: </strong>The retrospective analysis included 29 patients with SLE. Cutaneous disease activity was assessed using the Cutaneous Lupus Erythematosus Disease Area and Severity Index (CLASI) and the Revised CLASI (RCLASI) activity scores before treatment with belimumab and at 3, 6, 12, and up to 60 months of treatment. Eleven patients were treated for the whole observation period; however, only 8 patients were evaluable at 48 months, and only 6 at 60 months due to loss of follow-up.</p><p><strong>Results: </strong>Compared to the baseline score, a significant reduction of the CLASI and RCLASI activity score was seen during the treatment (mean CLASI baseline 8.76 ± 5.12, after 3 months 5.59 ± 3.87, p < 0.001, after 60 months 4.67 ± 3.86, p = 0.017; mean RCLASI baseline 10.93 ± 6.57, after 3 months 7.62 ± 6.03, after 60 months 5.33 ± 4.31, p = 0.012). The percentage of patients achieving a CLASI 100 response increased continuously over time, reaching a maximum of 30% after 60 months. Response was most remarkable among patients with acute or discoid cutaneous lupus. The treatment was well tolerated by the patients, with the most common adverse events being respiratory infections, headaches, and arthralgia, among others.</p><p><strong>Conclusion: </strong>This retrospective analysis demonstrated that belimumab has long-term benefits for cutaneous manifestations of patients with lupus erythematosus. However, prospective studies in larger patient populations are needed to confirm the findings.</p>","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bo Young Moon, Won Hee Lee, Eun Hye Jeong, Min Chong Kim, Young Kyung Bae, Dong Hoon Shin, Jong Soo Choi, Joon Goon Kim
{"title":"Giant Palmar Merkel Cell Carcinoma With Prolonged Stability and Abrupt Progression.","authors":"Bo Young Moon, Won Hee Lee, Eun Hye Jeong, Min Chong Kim, Young Kyung Bae, Dong Hoon Shin, Jong Soo Choi, Joon Goon Kim","doi":"10.1111/ijd.70303","DOIUrl":"https://doi.org/10.1111/ijd.70303","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Andrea Corio, Maria Rosaria Zampino, Nicola di Meo, Iris Zalaudek
{"title":"Targeting Intracellular Calcium Dysregulation in Hailey-Hailey Disease: A Case-Based Rationale for Oral Magnesium Chloride Therapy.","authors":"Andrea Corio, Maria Rosaria Zampino, Nicola di Meo, Iris Zalaudek","doi":"10.1111/ijd.70294","DOIUrl":"https://doi.org/10.1111/ijd.70294","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Omalizumab in Infant Facial Mastocytoma: 36-Month Efficacy and Safety Study.","authors":"Qingyang Zhao, Lin Ma, Juan Sun","doi":"10.1111/ijd.70275","DOIUrl":"https://doi.org/10.1111/ijd.70275","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katelyn Stenger, Heather M Zimmerman, Ralina Karagenova, Lauryn Liao, David J Elpern, Douglas W Johnson
{"title":"Delayed Diagnosis of Disseminated Cutaneous Mycobacterium chelonae: A Diagnostic Pitfall in Immunosuppressed Patients.","authors":"Katelyn Stenger, Heather M Zimmerman, Ralina Karagenova, Lauryn Liao, David J Elpern, Douglas W Johnson","doi":"10.1111/ijd.70297","DOIUrl":"https://doi.org/10.1111/ijd.70297","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marta Szepietowska, Bartosz Lisicki, Magdalena Krajewska, Andrzej K Jaworek, Jacek C Szepietowski
{"title":"Half-and-Half Nails in Maintenance Hemodialysis Patients: A Cross-Sectional Study of 104 Patients.","authors":"Marta Szepietowska, Bartosz Lisicki, Magdalena Krajewska, Andrzej K Jaworek, Jacek C Szepietowski","doi":"10.1111/ijd.70302","DOIUrl":"https://doi.org/10.1111/ijd.70302","url":null,"abstract":"","PeriodicalId":13950,"journal":{"name":"International Journal of Dermatology","volume":" ","pages":""},"PeriodicalIF":3.2,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146010136","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号